prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Pathologic Interpretation: A. Sentinel node #1 CT41 left axilla: - No carcinoma seen in one lymph node (0/1). - Keratin immunohistochemistry pending. B. Left axilla sentinel node #2 count : - No carcinoma seen in one lymph node (0/1). - Keratin Immunohistochemistry pending. C. Right axilla sentinel node #1 count. - No carcinoma seen in one lymph node (0/1). - Keratin immunohistochemistry pending. D. Left breast: - INFILTRATING DUCTAL CARCINOMA, poorly differentiated, Nottingham grade 3 (3+3+3=9), 6.0 cm in greatest. dimension. - The tumor Infiltrates the dermis. - Lymphovascular invasion is not identified. - Margins free of tumor. - See tumor summary. Tumor Summary (Invasive Carcinoma of the Breast) (D): Specimen Type: Partial breast. Procedure: Total mastectomy (including nipple and skin). Lymph Node Sampling: Sentinel lymph node(s). Specimen Integrity: Single intact specimen (margins can be evaluated). Specimen Laterality: Left. Tumor Size: Size of Largest Invasive Carcinoma: Greatest dimension of largest focus of invasion: 6.0 cm. Additional dimensions: 5.5 x 4.0 cm. Tumor Focality: Single focus of invasive carcinoma. Macroscopic and Microscopic Extent of Tumor: Skln: Invasive carcinoma directly invades into the dermis or epidermis without skin ulceration. Skeletal Muscle: Skeletal muscle is present and is free of carcinoma. Ductal Carcinoma in Situ: No DCIS is present. Histologic Type of Invasive Carcinoma: Invasive ductal carcinoma (no special type or not otherwise specified). Histologic Grade: Glandular (Acinar)/Tubular Differentiation: Score 3. Nuclear Pleomorphism: Score 3. Mitotic Count: Score 3. Overall Grade: Grade 3. Margins: Uninvolved by invasive carcinoma. Distance from closest margin: 15 mm (inferior). Specify margins: Distance from posterior margin: 20 mm. Treatment Effect: Response to Presurgical Therapy: in the breast: No known presurgical therapy. In the lymph nodes: No known presurgical therapy. Lymph-Vascular Invasion: Not identified. Dermal Lymph-Vascular Invasion: Not identified. Lymph Nodes: Number of sentinel lymph nodes examined: 2. Total number of lymph nodes examined (sentinel and nonsentinel): 0. Number of lymph nodes with macrometastases: 0. Number of lymph nodes with micrometastases: 0. SURGICAL PATHOL Report. Number of lymph nodes with isolated tumor cells: 0. Method of Evaluation of Sentinel Lymph Nodes: Hematoxylin and eosin (H&E), one level. Immunohistochemistry pending. Pathologic Staging (pTNM). Primary Tumor: pT3. Regional Lymph Nodes: Modifier: sn. Category: pNO (pending immunohistochemistry). Distant Metastasis: Not applicable. Anciliary Studies: Estrogen Receptor: Pending. Progesterone Receptor: Pending. Her2: Pending. AJCC classification 17th ed) pT3 snNo MX (pending evaluation of keratin In sentinel nodes). E. Right breast: - DUCTAL CARCINOMA IN SITU, intermediate grade (DIN2) with expansive necrosis, solid and cribriform types. - The largest focus is 3 mm, and it is present in 3/15 slides. - Resection margins negative. - Proliferative fibrocystic changes including intraductal papilloma (5 mm), columnar cell changes without atypla, apocrine. cell metaplasia, stromal fibrosis and microcyst formation. - See tumor summary. - Two fibroadenoma, largest 11 mm. Tumor Summary (DCIS OF THE BREAST) (E): Specimen Type: Total breast (including nipple and skin). Procedure: Total mastectomy (including nipple and skin). Lymph Node Sampling: Sentinel lymph node(s). Specimen Integrity: Single intact specimen (margins can be evaluated). Specimen Laterality: Right. Tumor Size: Size of Largest Invasive Carcinoma: Greatest dimension of largest focus of invasion: 0.3 cm. Number of blocks with DCIS: 3. Number of blocks examined: 15. Histologic Type: Ductal carcinoma in situ. Classified as Tis (DCIS) or Tis (Paget). Architectural Patterns: Cribriform. Solid. Nuclear Grade: Grade Il (intermediate). Necrosis: Present, central (expansive "comedo" necrosis). Margins: Involved by DCIS. Distance from closest margin: 2mm. Treatment Effect: Response to Presurgical Therapy: No known presurgical therapy. Lymph Nodes: Number of sentinel lymph nodes examined: 1. Total number of lymph nodes examined (sentinel and nonsentinel): 1. Number of lymph nodes with macrometastases: 0. Number of lymph nodes with micrometastases: 0. Number of lymph nodes with Isolated tumor cells: 0. Size of largest metastatic deposit: 0. Method of Evaluation of Sentinel Lymph Nodes: Hematoxylin and eosin (H&E), one level. Immunohistochemistry pending. Pathologic Staging (pTNM). Primary Tumor: pTis (DCIS). Regional Lymph Nodes: Modifier: sn. Category: pNO (pending immunohistochemistry). Distant Metastasis: Not applicable. Anciliary Studies: SURGICAL PATHOL Report. Estrogen Receptor: Pending. Progesterone Receptor: Pending. AJCC classification (7th ed) pTis (DCIS) snNo MX (pending evaluation of keratin in sentinel nodes). NOTE: Some immunohistochemical antibodies are analyte specific reagents (ASRs) validated by our laboratory (Her 2, Parvo, H. pylori, HBcore). These ASRs are clinically useful indicators that do. not require FDA approval. These clones are used: ID6=ER, POR 636=PR, A485=HER2, H-11=EGFR, CCH2DDG9=CMV, F39.4. 1=AR and HPV by ISH. AN immunohistochemical stains are used. with formalin or molecular fixed, paraffin embedded tissue. Detection is by LSAB. The results are read by a pathologist as positive or negative. As the attending pathologist, / attest that 1: " Examined the relevant. preparation(s) for the specimen(s): and (i) Rendered the diagnosis(es). Procedures/Addenda. Addendum. 1. Date Complete: Addendum Diagnosis. A. Sentinel Node #1, Left Axilla: Immunohistochemistry for keratin is negative. B. Left Axilla Sentinel Node #2: Immunohistochemistry for keratin is negative. C. Right Axilia Sentinel Node #1: Immunohistochemistry for keratin is negative. D. Left Breast : The tumor cells are positive for ER and PR (focally). They are negative for HER2 (score 0) by. immunohistochemistry. Final AJCC staging: pT3, snNO(i), Mn/a. E. Right Breast: The tumor cells are positive for ER and PR by immunohistochemistry. Final AJCC staging: pTis (DCIS) snNo(1-), M n/a. MD, PhD. Intraoperative Consultation. A. Sentinel node #1 CT41 left axilla touchprep: No carcinoma seen in frozen section and touch prep. Final diagnosis defer for permanent. B. Left axilla sentinel node #2 count 31 touch prep: No carcinoma seen in frozen section and touch prep. Final diagnosis defer for permanent. C. Right axilla sentinel node #1 count 79 Touch prep: No carcinoma seen in frozen section and touch prep. Final diagnosis defer for permanent. SURGICAL PATHOL Report. Clinical History: Not provided. Pre Operative Diagnosis: Not provided. Specimen(s) Received: A: Sentinel node #1 CT41 left axilla touchprep. B: Left axilla sentinel node #2 count 31 touch prep. C: Right axilla sentinel node #1 count 79 Touch prep. D: Left breast (1 stitich superior, 2 lateral, Fresh). E: Right breast (1 stitich superior, 2 lateral, Fresh). Gross Description: A. Received fresh and labeled "sentinel node #1. left axilla, touch prep" is a yellow-tan, irregular-shaped, soft tissue. fragment measuring 1.5 x 1.5 x 1.0 cm. Specimen bisected and submitted in toto in one cassette for frozen section. B. Received fresh and labeled "left axilla sentinel node #2 count 31, touch prep" is a yellow-tan, fibrofatty tissue measuring. 1.5 x 1.0 x 1.0 cm. Specimen Is bisected and submitted in toto in one cassette for frozen section and touch prep. C. Received fresh and labeled "right axilla sentinel node #1 count 79, touch prep" is a yellow-tan, irregular-shaped, soft. tissue fragment measuring 2.0 x 1.0 x 1.0 cm. Specimen bisected and submitted in toto in one cassette for frozen section. and touch prep. D. Received fresh and labeled "left breast (1 stitich superior, 2 lateral)" is a left radical modified mastectomy measuring 21.0. x 19.0 x 4.0 cm and weighs 750 grams. The skin is light tan, ellipse, measuring 21.0 x 16.0 cm. Areola is 6.0 cm In. maximum diameter and nipple is impressed and very hard measuring 2.5 cm in maximum diameter. The specimen is. oriented with one stitch at superior and two stitches at lateral. The surgical margin is inked in black. Sectioning reveals a. yellow-gray, well defined, tumoral mass measuring 6.0 x 5.5 x 4.0 cm. This tumor is 60% necrotic with focal hemorrhage. No calcification is noted grossly. This tumor is located beneath of nipple. The remainder of mammary tissue is. yellow-white, fibrofatty tissue. No other lesions Is identified grossly. This tumor is located at less than 0.1 cm from. superficial (skin nipple), at 1.5 cm from inferior surgical margin, at 2.0 cm from deep surgical margin and the rest of the. surgical margins are away more than 4.0 cm from this tumor. The specimen is submitted in fifteen cassettes as follows: 1. Perpendicular section superior margin. 2. Perpendicular section inferior margin. 3. Perpendicular section medial margin. 4. Perpendicular section lateral margin. 5. Perpendicular section of nipple in relation with tumor. 6. Perpendicular section deep margin. 7. Tumor in relation with nipple and skin. 8&9. Hemorrhagic and necrotic area. 10-13. Tumor. 14&15. Mammary tissue. E. Received fresh and labeled "right breast (1 stitich superior, 2 lateral)" is a right radical modified mastectomy measuring. 20.0 x 15.0 x 4.0 cm and weighs 522 grams. The skin is light tan ellipse measuring 16.0 x 14.0 cm. Areola measures 6.5. cm in maximum diameter. The nipple measures 1.5 cm in diameter. The specimen is oriented with one stitch at superior. and two stitches at lateral. The resection margin is inked In black. Sectioning reveals gray-tan, fibrocystic area measuring. 7.0 x 7.0 x 3.0 cm, located at 1.0 cm from inferior surgical margin, at 2.0 cm from medial margin, at 3.0 cm from lateral. margin, at 3.5 cm from superior margin, at 0.5 cm from deep surgical margin and immediately beneath the nipple. Deep. fibrocystic area has multiple cysts up to 1.0 cm in maximum diameter. The cysts are filled by brown-tan chocolate and. green tan puruient material. Remainder of mammary tissue is gray-tan, fibrofatty tissue, unremarkable. grossly. other. suspicious lesions are identified grossly. Submitted in fifteen cassettes as follows: 1. Perpendicular section superior margin. 2. Perpendicular section inferior margin. 3. Perpendicular section medial margin. 4. Perpendicular section lateral margin. SURGICAL PATHOL Report. 5. Bisected of nipple. 6. Perpendicular section deep margin. 7. Necrotic tissue. 8. Hemorrhagic necrotic area with deep surgical margin. 9-14. Fibrocystic and necrotic mammary tissue. 15. Unremarkable mammary tissue. ICD-9(s): 174.8 233.0.

expanded version (tokens=3253) : 
 The breast pathology report contains information about the following:

1. Histological Classification:
   a. Left Breast:
      - Invasive Ductal Carcinoma (poorly differentiated), Nottingham Grade 3.
   b. Right Breast:
      - Ductal Carcinoma In Situ (DCIS), intermediate grade (DIN2) with expansive necrosis, solid and cribriform types.

2. Subtype:
   a. Left Breast: Not specified.
   b. Right Breast: DCIS with expansive necrosis, solid and cribriform types.

3. Necrosis:
   a. Left Breast: Not identified.
   b. Right Breast: Central (expansive "comedo" necrosis).

4. Tumor Infiltrating Lymphocytes: Not mentioned in the report.

5. Histological Grade:
   a. Left Breast: Glandular (Acinar)/Tubular Differentiation: Score 3; Nuclear Pleomorphism: Score 3; Mitotic Count: Score 3; Overall Grade: Grade 3.
   b. Right Breast: Nuclear Grade: Grade Il (intermediate).

6. Nuclear Grade: 
   a. Left Breast: Score 3.
   b. Right Breast: Grade II (intermediate).

7. Lymphovascular Invasion: Not identified in either breast.

8. Calcification: Not mentioned in the report.

9. Receptor Status:
   a. Left Breast: ER

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=3414) : 
 The pathology report shows a poorly differentiated Invasive Ductal Carcinoma (Grade 3) in the left breast without tumor infiltrating lymphocytes and with negative lymphovascular invasion. The tumor cells are ER+ and PR+ (focally), but HER2 negative. The right breast shows intermediate-grade DCIS with necrosis, solid and cribriform types, having involved margins positive for DCIS according to the report. The sample has been sent out for further lab testing, including receptor status for estrogen, progesterone, and HER2.

